What Melanotan I is
Melanotan I is a selective MC1R agonist. A linear alpha-MSH analogue with greater selectivity for MC1R than MT2, so it is studied primarily for melanogenesis without the broader melanocortin effects.
Class and mechanism
Melanotan I is a selective MC1R agonist. A linear alpha-MSH analogue with greater selectivity for MC1R than MT2, so it is studied primarily for melanogenesis without the broader melanocortin effects.
Where it sits
Wellbeing compounds are grouped by the outcome they are studied for rather than by shared chemistry, so the class column varies widely across the group.
Other names
Melanotan I is also written as Afamelanotide and MT-1. The same molecule appears under more than one name, which is worth knowing when comparing listings between suppliers.
Others in the wellbeing compounds range
Melanotan I sits in the wellbeing compounds group. The compounds below share that grouping, which is the useful starting point when comparing one against another: same group means the comparison is like for like, different group usually means it is not.
| Compound | Class | Listings | From |
|---|---|---|---|
| Melanotan II | Non-selective melanocortin agonist | 3 | £15 |
| PT-141 | Melanocortin receptor agonist | 2 | £20 |
| Selank | Anxiolytic heptapeptide | 1 | £30 |
| Semax | ACTH(4-10) analogue | 1 | £30 |
| Kisspeptin-10 | KISS1R agonist | 1 | £50 |
| Cialis | PDE5 inhibitor | 1 | £12 |
Is it held in UK stock?
Stock held in the UK ships domestically, with no customs step. The product page carries live stock rather than a cached figure.
What is Melanotan I?
Melanotan I is a selective MC1R agonist. A linear alpha-MSH analogue with greater selectivity for MC1R than MT2, so it is studied primarily for melanogenesis without the broader melanocortin effects.
- SerenQ Melanotan-1 15mg Peptide Penout of stock£50
Availability checked 2026-09-09. The product page carries live stock.